| Track 1: Electrolyte Disorders and Physiology |
| Track 1-1: |
Acid-Base studies |
| Track 1-2: |
Water/Urea/Vasopressin and organic osmolytes |
| Track 1-3: |
Inorganic ions (Na, K, Cl) and epithelial biology |
| Track 1-4: |
Inorganic ions: Ca, Mg and phosphate |
| Track 1-5: |
ICU nephrology/ Na, and K Disorders |
| Track 2: Hemodynamics, Hypertension, and Vascular Regulation |
| Track 2-1: |
Hypertension |
| Track 2-2: |
Vascular physiology/Renal hemodynamics |
| Track 2-3: |
Vascular pathology |
| Track 3: Hereditary Disorders in Nephrology |
| Track 3-1: |
Cystic and other inherited kidney diseases |
| Track 3-2: |
Genetic kidney diseases |
| Track 3-3: |
Genetic epidemiology |
| Track 3-4: |
Genomics/proteomics/systems biology of renal disease |
| Track 4: Pathophysiology of Renal Diseases |
| Track 4-1: |
Acute kidney injury (AKI) |
| Track 4-2: |
Diabetes mellitus (DM) |
| Track 4-3: |
Chronic kidney disease(CKD) |
| Track 5: Psychological Aspects in Dialysis |
| Track 5-1: |
Medication adherence in dialysis |
| Track 5-2: |
Health related quality of life in dialysis |
| Track 5-3: |
Assessment of depression & anxiety in patients undergoing dialysis |
| Track 6: Renal Transplantation |
| Track 6-1: |
Transplantation related ethical issues |
| Track 6-2: |
Transplantation immunobiology and tolerance |
| Track 6-3: |
Epidemiology, outcomes |
| Track 6-4: |
Pathology of renal transplant rejection |
| Track 6-5: |
Post transplantation complications |
| Track 7: Dialysis |
| Track 7-1: |
Hemodialysis and other renal replacement therapies |
| Track 7-2: |
Dialysis for AKI |
| Track 7-3: |
Hemodialysis: Vascular access |
| Track 7-4: |
Home dialysis: pd and other techniques |
| Track 7-5: |
Inflammation and oxidation |
| Track 7-6: |
Dialysis: Anemia, Malnutrition, and Metabolism |
| Track 7-7: |
Epidemiology outcomes and clinical trials: Cardiovascular |
| Track 8: Renal Pathology |
| Track 8-1: |
Basic/experimental immunology |
| Track 8-2: |
Basic/experimental inflammation |
| Track 8-3: |
Basic/experimental pathology |
| Track 8-4: |
Extracellular matrix biology, fibrosis, and cell adhesion |
| Track 8-5: |
Cell biology of the glomerulus |
| Track 8-6: |
Clinical/diagnostic renal pathology and laboratory medicine |
| Track 9: CKD, AKI, DM Clinical |
| Track 9-1: |
Chronic kidney disease and its complications |
| Track 9-2: |
Clinical trials, health services research, and ethics |
| Track 9-3: |
Glomerular disorders |
| Track 9-4: |
Diabetes mellitus and its complications including nephropathy |
| Track 9-5: |
Urological disorders |
| Track 10: Mediators, Signaling, Cell Growth, Apoptosis and Neoplasia |
| Track 10-1: |
Hormones/peptides/growth Factors |
| Track 10-2: |
Cell signaling |
| Track 10-3: |
Cell growth, cell proliferation, apoptosis and neoplasia |
| Track 11: Bone and Mineral Diseases and Kidney Stones |
| Track 11-1: |
Renal osteodystrophy |
| Track 11-2: |
Calcium/Magnesium/Phosphorus and Stones |
| Track 11-3: |
Parathyroid hormone/Vitamin D/ Phosphatonins |
| Track 12: Advanced and Innovative Technologies Associated with the Nephrology |
| Track 12-1: |
Hemodynamics and fluid dynamics |
| Track 12-2: |
Local delivery of drugs, cells, genes and chemicals |
| Track 12-3: |
Biomarkers research in renal diseases |
| Track 12-4: |
Imaging |
| Track 12-5: |
Advanced and innovative technologies |
RSS
Facebook
LinkedIn
Twitter
Blog